SCHEMBL22010624

SCHEMBL22010624

COC(=O)c1ccc(C)cc1S(N)(=O)=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.63
CA1 P00915 4/20 0.63
CA9 Q16790 4/20 0.63
CA5A P35218 1/20 0.63
GAA P10253 2/20 0.51
CA12 O43570 3/20 0.46
CA7 P43166 2/20 0.46
CA14 Q9ULX7 2/20 0.46
PDK2 Q15119 1/20 0.46
PDK4 Q16654 1/20 0.46
NR4A2 P43354 2/20 0.45
HPGD P15428 2/20 0.45
LMNA P02545 1/20 0.45
CYP46A1 Q9Y6A2 1/20 0.44
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
ATM Q13315 2/20 0.44
HSD17B10 Q99714 2/20 0.44
GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9437987 0.85 CA1 (0.47) CA2CA1CA9CA5AGAA
SCHEMBL16904960 0.85 CA1 (0.47) CA2CA1CA9CA5AGAA
SCHEMBL8030650 0.85 GAA (0.67) CA2CA1CA9CA5AGAA
SCHEMBL27503010 0.84 CA1 (0.47) CA2CA1CA9CA5AGAA
SCHEMBL19194044 0.83 CA1 (0.46) CA2CA1CA9CA5AGAA
SCHEMBL11372105 0.83 CA1 (0.63) CA2CA1CA9CA5AGAA
SCHEMBL9316923 0.83 CA1 (0.46) CA2CA1CA9CA5AGAA
SCHEMBL9317325 0.83 CA1 (0.46) CA2CA1CA9CA5AGAA
SCHEMBL21962924 0.82 CA2 (0.61) CA2CA1CA9CA5AGAA
SCHEMBL21962894 0.82 CA2 (0.61) CA2CA1CA9CA5AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102100-A9 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2022-01-06 WO disclosed
WO-2020102100-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed